The surgical treatment of benign prostatic obstruction is changing over the time, thanks the increase evidence about the successful role of laser techniques in this surgery. We aimed to compare prostatic GreenLight photovaporization (PVP) to bipolar transurethral resection of the prostate (TURP) with regard to lower urinary tract symptoms (LUTS) improvement through the evaluation of BPH6. We enrolled 220 consecutive subjects affected by LUTS. We performed a propensity score matching using prostate volume, peak flow and International Prostate Symptoms Score (IPSS). A total of 110 (55 TURP and 55 PVP) were analyzed. We found after 1 year of follow-up that the rate of subjects resulting in greater BPH6 recovery in the PVP group vs TURP (45.6% vs 18.2%; P=0.001). The TURP treatment showed greater catheterization time (4.67 vs 1.25; P<0.01) while PVP showed greater recovery experience (82.4 vs 58.2; <0.01). Postoperative ejaculatory dysfunctions were observed in both groups, 58.8% in TURP and 34.5% in PVP group. The multivariate logistic regression analysis, adjusted for preoperative variables, showed that PVP was independently associated with BPH6 recovery end point (odds ratio=3.77; P<0.01). This study showed data in favor of PVP. Although IPSS and peak flow improvements were similar, PVP showed better clinical outcomes.
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
de la Rosette J, Elhilali M, Naito S, Unal D, Razvi H, Liatsikos E et al. Clinical Research Office of the Endourological Society Global GreenLight Laser Study: outcomes from a contemporary series of 713 patients. Int J Urol 2015; 22: 1124–1130.
Favilla V, Cimino S, Salamone C, Fragala E, Madonia M, Condorelli R et al. Risk factors of sexual dysfunction after transurethral resection of the prostate (TURP): a 12 months follow-up. J Endocrinol Invest 2013; 36: 1094–1098.
Russo GI, Castelli T, Urzi D, Privitera S, La Vignera S, Condorelli RA et al. Emerging links between non-neurogenic lower urinary tract symptoms secondary to benign prostatic obstruction, metabolic syndrome and its components: a systematicreview. Int J Urol 2015; 22: 982–990.
Russo GI, Cimino S, Fragala E, Privitera S, La Vignera S, Condorelli R et al. Relationship between non-alcoholic fatty liver disease and benign prostatic hyperplasia/lower urinary tract symptoms: new insights from an Italian cross-sectional study. World J Urol 2015; 33: 743–751.
Vanella L, Russo GI, Cimino S, Fragala E, Favilla V, Li Volti G et al. Correlation between lipid profile and heme oxygenase system in patients with benign prostatic hyperplasia. Urology 2014; 83: 1444 e7–13.
Rieken M, Bachmann A . Update on Greenlight laser vaporization (PVP) 2014. World J Urol 2015; 33: 531–537.
Lee R, Gonzalez RR, Te AE . The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia. World J Urol 2006; 24: 405–409.
Thomas JA, Tubaro A, Barber N, d'Ancona F, Muir G, Witzsch U et al. A Multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr outcomes of the GOLIATH Study. Eur Urol 2016; 69: 94–102.
Sonksen J, Barber NJ, Speakman MJ, Berges R, Wetterauer U, Greene D et al. Prospective, randomized, multinational study of prostatic urethral lift versus transurethral resection of the prostate: 12-month results from the BPH6 study. Eur Urol 2015; 68: 643–652.
Lee JH, Lee SW . Impact of prostate volume on erectile dysfunction and premature ejaculation. Aging Male 2016; 19: 106–110.
Patel VR, Sivaraman A, Coelho RF, Chauhan S, Palmer KJ, Orvieto MA et al. Pentafecta: a new concept for reporting outcomes of robot-assisted laparoscopic radical prostatectomy. Eur Urol 2011; 59: 702–707.
Roehrborn CG, Wilson TH, Black LK . Quantifying the contribution of symptom improvement to satisfaction of men with moderate to severe benign prostatic hyperplasia: 4-year data from the CombAT trial. J Urol 2012; 187: 1732–1738.
Kluivers KB, Riphagen I, Vierhout ME, Brolmann HA, de Vet HC . Systematic review on recovery specific quality-of-life instruments. Surgery 2008; 143: 206–215.
Cappelleri JC, Rosen RC . The Sexual Health Inventory for Men (SHIM): a 5-year review of research and clinical experience. Int J Impot Res 2005; 17: 307–319.
Rosen RC, Catania JA, Althof SE, Pollack LM, O'Leary M, Seftel AD et al. Development and validation of four-item version of Male Sexual Health Questionnaire to assess ejaculatory dysfunction. Urology 2007; 69: 805–809.
Sandvik H, Seim A, Vanvik A, Hunskaar S . A severity index for epidemiological surveys of female urinary incontinence: comparison with 48-hour pad-weighingtests. Neurourol Urodyn 2000; 19: 137–145.
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250: 187–196.
Bach T, Wolbling F, Gross AJ, Netsch C, Tauber S, Pottek T et al. Prospective assessment of perioperative course in 2648 patients after surgical treatment of benign prostatic obstruction. World J Urol 2017; 35: 285–292.
Guo S, Muller G, Lehmann K, Talimi S, Bonkat G, Puschel H et al. The 80-W KTP GreenLight laser vaporization of the prostate versus transurethral resection of the prostate (TURP): adjusted analysis of 5-year results of a prospective non-randomized bi-center study. Lasers Med Sci 2015; 30: 1147–1151.
Cakiroglu B, Sinanoglu O, Dogan AN . Safety of greenlight photoselective vaporisation of prostate in lower urinary tract symptoms due to benign prostatic hyperplasia in patients using anticoagulants due to cardiovascular comorbidities. Arch Ital Urol Androl 2015; 87: 141–143.
Pawan V, Anup K, Niraj K, Biswajit N, Punita R, Rajendra A et al. Safety and efficacy of photoselective vaporization of prostate in patients receiving anticoagulants. Minerva Urol Nefrol 2013; 65: 189–195.
Zhou Y, Xue B, Mohammad NA, Chen D, Sun X, Yang J et al. Greenlight high-performance system (HPS) 120-W laser vaporization versus transurethral resection of the prostate for the treatment of benign prostatic hyperplasia: a meta-analysis of the published results of randomized controlled trials. Lasers Med Sci 2016; 31: 485–495.
Lukacs B, Loeffler J, Bruyere F, Blanchet P, Gelet A, Coloby P et al. Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial. Eur Urol 2012; 61: 1165–1173.
Rosen R, Altwein J, Boyle P, Kirby RS, Lukacs B, Meuleman E et al. Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7). Eur Urol 2003; 44: 637–649.
McVary KT . Erectile dysfunction and lower urinary tract symptoms secondary to BPH. Eur Urol 2005; 47: 838–845.
Kassabian VS . Sexual function in patients treated for benign prostatic hyperplasia. Lancet 2003; 361: 60–62.
Li Z, Chen P, Wang J, Mao Q, Xiang H, Wang X et al. The impact of surgical treatments for lower urinary tract symptoms/benign prostatic hyperplasia on male erectile function: a systematic review and network meta-analysis. Medicine (Baltimore) 2016; 95: e3862.
Kumar N, Vasudeva P, Kumar A, Singh H . Prospective randomized comparison of monopolar TURP, bipolar TURP and photoselective vaporization of the prostate in patients with benign prostatic obstruction: 36 months outcome. Low Urin Tract Symptoms 2016. doi: 10.1111/luts.12135.
All participants provided written informed consent before enrollment and the study was conducted in accordance with regulatory standards of Good Clinical Practice and the Declaration of Helsinki (1996). The study was approved by our Institutional Research Ethics Committee.
The authors declare no conflict of interest.
Supplementary Information accompanies the paper on International Journal of Impotence Research website
About this article
Cite this article
Cimino, S., Voce, S., Palmieri, F. et al. Transurethral resection of the prostate (TURP) vs GreenLight photoselective vaporization of benign prostatic hyperplasia: analysis of BPH6 outcomes after 1 year of follow-up. Int J Impot Res 29, 240–243 (2017). https://doi.org/10.1038/ijir.2017.30
This article is cited by
Comparison of bipolar plasmakinetic resection of prostate versus photoselective vaporization of prostate by a three year retrospective observational study
Scientific Reports (2021)
Lasers versus bipolar technology in the transurethral treatment of benign prostatic enlargement: a systematic review and meta-analysis of comparative studies
World Journal of Urology (2020)
“Aquabeam® System” for benign prostatic hyperplasia and LUTS: birth of a new era. A systematic review of functional and sexual outcome and adverse events of the technique
International Journal of Impotence Research (2019)